2011-2012 Friday Infectious Disease Conference Schedule

2011-2012 Conference Schedule


Date Speaker Title or Topic
September 9, 2011 Edwin Cameron
Constutional Court, South Africa
Robert Coombs, MD, PhD, FRCPC
University of Washington
"The Constitution and HIV/AIDS: the personal and the political"

"Laboratory medicine can have tsunamis, too: the case for simple/rapid HIV RNA testing"
September 16, 2011 Meredith Shiels, PhD
National Cancer Institute

"Aging and cancer in HIV-infected individuals"

September 23, 2011 Richard W. Price, MD  
University of California - San Francisco
“Evaluating and treating CNS HIV infection in the current era”
September 30, 2011 Brian W. Pence, PhD
Duke University
Brad Gaynes, MD, MPH
UNC-Chapel Hill
"Depression in HIV primary care"
October 7, 2011 Jim Thomas, PhD
UNC-Chapel Hill
“Inter-organizational network analysis for HIV care”
October 14, 2011 Judith Auerbach, PhD
San Francisco AIDS Foundation
"Thirty years of HIV/AIDS research: the view from the 'nasty sciences'"
October 21, 2011 Marcia Hobbs, PhD
UNC-Chapel Hill
"Performance of reverse sequence syphilis testing in Jamaica"
October 28, 2011 Joseph Tucker, MD
Harvard University/
UNC-Chapel Hill
”The Spatial Organization of Unsafe Sex: Progress towards Spatially Targeted Syphilis Control Measures in Guangdong Province, China"
November 4, 2011 Daniel Westreich, PhD
Duke Universityl
“Pregnancy and antiretroviral therapy in South Africa”
November 11, 2011 Jeff Stringer, MD
Ben Chi, MD, MSc
Stewart Reid, MD, MPH 
Centre for Infectious Disease Research in Zambia
"A global health program in Zambia"
November 18, 2011 Jon Juliano, MD
Irving Hoffman, PA, MPH
UNC-Chapel Hill
"Next generation sequencing for next generation malaria vaccines: implications of parasite diversity on  malaria vaccine efficacy"
"Phase III RTS,S/AS01 malaria vaccine trial in African children: first results on efficacy and safety"
December 2, 2011 Keymanthri Moodley, PhD
University of Stellenbosch
"The Ethics of HIV Prevention Research: Experiences in South Africa"
December 9, 2011 Omar Glarraga, MA, PhD
Brown University
“Willingness to Accept Conditional Economic Incentives to Reduce HIV Risks among men who have sex with men in Mexico City”
December 16, 2011 Lynn Matthews, PhD
Harvard University

"Minimizing HIV transmission among serodiscordant couples who choose to conceive"

December 23 and 30, 2011 HOLIDAY NO CONFERENCE
January 6, 2012 William Miller, MD, MPH
UNC-Chapel Hill
“The scourge of community viral load” and “STIs in space” (Donuts discussed at intermission)
January 13, 2012 David Weber, MD, MPH
UNC-Chapel Hill
“New Advisory Committee on Immunization Practices (ACIP) Vaccine Guidelines”
January 20, 2012 Carol Golin, MD
Julie Nelson, PhD
Michael Hudgens, PhD
UNC-Chapel Hill
“UNC CFAR: Updates on Social and Behavioral Science, Virology, and Biostatistics”
January 27, 2012 Kristina Abel, PhD
UNC-Chapel Hill
“A Novel Pediatric HIV-TB Combination Vaccine”
February 3, 2012 Vance Fowler, MD, MHS
Duke University
“Staphylococcus aureus: Lessons Learned from 20 Years with the Persistent Pathogen”
February 10, 2012 Manish Sagar, MD
Harvard University
“Selection and antibody susceptibility during heterosexual HIV-1 transmission”
February 17, 2012 Annelies van Rie, PhD
UNC-Chapel Hill
“TB diagnosis: smear microscopy, Xpert and beyond”
February 24, 2012 Byrd Quinlivan, MD
UNC-Chapel Hill
Lynne Messer, MD
Duke Global Health Institute
"HIV-positive women of color and reflections on care"
March 2, 2012 Peadar Noone, MD
UNC-Chapel Hill
"An Update on Cystic fibrosis"
March 9, 2012 Irene Doherty, PhD
UNC-Chapel Hill
“Syphilis, Surveillance, and Sexual Networks”
March 16, 2012 David Wohl, MD
David Margolis, MD
Christopher Hurt, MD
UNC-Chapel Hill
"CROI Update"
March 23, 2012 Michelle Floris-Moore
UNC-Chapel Hill
"HIV and Vascular Inflammation"
March 30, 2012 Hendree Jones, PhD
RTI International
"Improving Outcomes and Reducing HIV Risk Among Drug Addicted Pregnant and Parenting Women in the US and Internationally: Medication Testing and Behavioral Treatment Development, Adaptation and Evaluation"
April 13, 2012 Anne Lachiewicz, MD, MPH; Melissa Miller, PhD; Ralph Raasch, PharmD
UNC-Chapel Hill
Can beta-lactam/beta-lactam inhibitor combinations be used to treat extended spectrum beta-lactamase producing E coli?”
April 20, 2012 Joe Eron, MD
UNC-Chapel Hill
“Antiretroviral therapy: new agents for HIV. What does the pipeline look like?”
April 27, 2012 Vicki Mobley, Ali Groves, Nora Rosenberg, Elizabeth Pollom
UNC-Chapel Hill
“An STD/HIV potpourri: the latest research from UNC trainees”
May 4, 2012 Joe Brown, PhD
London School of Hygiene and Tropical Medicine
“Water, sanitation, and hygiene and HIV: current research and opportunities”
May 11, 2012 Laura Widman, Lisa Parker, Pete Broglie
UNC-Chapel Hill
“Another STD/HIV potpourri: more of the latest research from UNC trainees”
May 18, 2012 Galit Alter, PhD
Harvard University
“Defining mechanisms of NK cell mediated control of chronic viral infections”
May 25, 2012 Harsha Thirumurthy, PhD
UNC-Chapel Hill
"Conditional cash transfer and mobile phone interventions to improve ART adherence in Kenya and Uganda”
June 1, 2012 Kimberly Powers, PhD
UNC-Chapel Hill
“Will Acute and Early HIV Infection Limit the Impact of HIV Treatment as Prevention?”
June 8, 2012 Ward Cates, MD
FHI 360
“The Hormonal Contraception/HIV Acquisition Enigma: The Plot Thickens”
June 15, 2012 Satish Gopal, MD, MPH
UNC-Chapel Hill
"HIV-associated Lymphoma in the United States” 
“Cancer in sub-Saharan Africa”
June 22, 2012 Jason Stout, MD
Duke University
“TB Clinical Trials: So Many Drugs, So Little Time”
June 29, 2012 Chris Woods, MD
Duke University
“A Program for Developing ‘omic Signatures for Early Detection of Infectious Diseases”